2004
DOI: 10.1002/hed.20012
|View full text |Cite
|
Sign up to set email alerts
|

Disease control, survival, and functional outcome after multimodal treatment for advanced‐stage tongue base cancer

Abstract: Although functional outcome may be decreased by certain surgical interventions and advanced T stage, the high rate of locoregional and distant disease control and excellent 2-year disease-specific survival supports an aggressive treatment regimen for advanced tongue base cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
29
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(30 citation statements)
references
References 31 publications
1
29
0
Order By: Relevance
“…2 Unfortunately, advances in surgery, radiotherapy, and chemotherapy have offered limited progress in terms of overall patient survival as regional failure and distant tumor recurrences continue to account for the disconcerting mortality rates over the last 2 decades. 3,4 The single greatest determinant of long-term patient survival remains early lesion detection and effective treatment. Presently, noninvasive imaging methods are unable to characterize the tissue microstructures in the epithelium and subepithelial layers.…”
Section: Arch Otolaryngol Head Neck Surg 2006;132:1074-1081mentioning
confidence: 99%
“…2 Unfortunately, advances in surgery, radiotherapy, and chemotherapy have offered limited progress in terms of overall patient survival as regional failure and distant tumor recurrences continue to account for the disconcerting mortality rates over the last 2 decades. 3,4 The single greatest determinant of long-term patient survival remains early lesion detection and effective treatment. Presently, noninvasive imaging methods are unable to characterize the tissue microstructures in the epithelium and subepithelial layers.…”
Section: Arch Otolaryngol Head Neck Surg 2006;132:1074-1081mentioning
confidence: 99%
“…Despite concerted efforts to improve treatments, 5 year survival rates for patients with advanced stage oral squamous cell carcinoma (oral SCC) remain among the lowest of solid cancers. Furthermore, even for those persons who are cured, morbidity remains high due to loss of tissues that are critical for esthetics and function (2). Another significant concern for persons diagnosed with oral SCC is the potential for tumor recurrence or the development of a second primary cancer (3)(4)(5).…”
Section: Introductionmentioning
confidence: 99%
“…10 In the case of resectable OSCC, the use of adjuvant chemotherapy is controversial: Some institutions propose the use of neoadjuvant chemoradiation, whereas others follow the surgery and/or radiotherapy alone concept. 11,12 Established chemotherapy regimens contain a combination of 5-fluorouracil (5-FU) with platinum-containing drugs, such as cisplatin and carboplatin. During past years, various strategies combining chemotherapy with radiotherapy were tested for their capability to improve treatment outcome.…”
mentioning
confidence: 99%